Related Experiment Video
Updated: Jul 15, 2025

07:51
Isolation of Leukocytes from the Murine Tissues at the Maternal-Fetal Interface
Published on: May 21, 2015
17.3K
Maternal IL-10 restricts fetal emergency myelopoiesis
Biorxiv : the Preprint Server for Biology
|September 25, 2023
Summary
Maternal interleukin-10 (IL-10) blocks fetal hematopoietic stem and progenitor cells (HSPCs) from activating emergency myelopoiesis, leading to neutropenia in newborns. This maternal anti-inflammatory response compromises fetal infection defense.
Area of Science:
- Immunology
- Developmental Biology
- Hematopoiesis
Background:
- Neonates exhibit heightened susceptibility to inflammation and infection compared to adults.
- Fetal hematopoietic stem and progenitor cells (HSPCs) are crucial for immune development but their response to inflammation is not fully understood.
Conclusions:
- Maternal IL-10 restricts fetal HSPCs from engaging EM pathways, impacting myeloid cell output.
- This restriction may explain neutropenia observed in septic neonates.
- An evolutionary trade-off exists between maintaining pregnancy via maternal anti-inflammatory factors and fetal immune responsiveness.
Related Concept Videos
Development of Immunocompetence
339
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
339
Regulation of Hematopoietic Stem Cells
3.2K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.2K
Transcytosis of IgG
2.8K
Transcytosis is the process in which molecules are internalized by endocytosis, transported across the cell, and released through exocytosis from the opposite end of the cell. Molecules such as insulin, immunoglobulins, and certain nutrients are transferred through the recycling endosomes by recycling and transcytosis.
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
2.8K

